Home > Back to Publisher > Report Information

Cardiac Rhythm Management (CRM) Devices

Global Industry Analysts
October 1, 2011
375 Pages - SKU: GJOB6711131

Abstract Table of Contents Related Reports

Countries covered: Global

This report analyzes the worldwide markets for Cardiac Rhythm Management (CRM) Devices in US$ Million by the following Product Segments: Implantable Cardioverter Defibrillators (ICD), Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) devices. The report provides separate comprehensive analytics for the US, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. A six-year historic analysis is also provided for these markets. The report profiles 48 companies including many key and niche players such as Bard Electrophysiology, Biosense Webster, Inc., Biotronik GMBH & Co. KG, Boston Scientific Corporation, Medtronic, Inc., Medtronic CryoCath LP, Vitatron Nederland BV, Philips Healthcare, St. Jude Medical, Inc., and Sorin Group. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS: Study Reliability and Reporting Limitations; Disclaimers; Data Interpretation & Reporting Level; Product Definitions and Scope of Study
2. INDUSTRY OVERVIEW: A Prelude; Cardiac Rhythm Management Devices - An Outlook; Market Structure
3. TRENDS & ISSUES: SSS and AV Block Incidence Triggers Demand for Pacemakers ……; Infamous Product Recalls Throw Growth Off-track; Market Shapes Up After the Recall Shock; Growing Proportion of Obese Population: A Major Demographic Driver; Replacements to Drive the Growth of ICDs; Developments in Energy-Based Therapies Augur Well for Cardiac Ablation Treatments; Expanding Applications Lend Traction to Growth; Prices of Cardiac Pacemakers Soften; Heart Patients Using ICD, Enjoy Satisfactory Quality Life; Pacemakers Ensure Effective Management of Non-Systolic Heart Failures; CRT: An Effective Treatment for Bradycardia, Tachycardia & Fibrillation; ICDs in Pediatric Care Shows Promise; Emerging Therapies for the Treatment of Atrial Fibrillation; New Generation CRM Devices Feature Superior Benefits; MRI-Compatible Pacemakers & ICDs; Resistance Against Electronic Interferences; Confusion Over the Use of CRM Devices Threaten Perceived Effectiveness; Breathing Disorders in Patients Implanted with Pacemakers: A Cause for Concern; Approval of Untested Pacemaker Connectors Raises Eyebrows; ICD Lead Failure Demands Immediate Attention; Pacemaker Hacking Has the Industry Up by Its Ears; Pacemakers Face Stiff Competition from CRT-D Devices; ICDs More Prone to Malfunction than Pacemakers; Conclusion; Technology Innovation: A Futuristic Rumination
4. PRODUCT OVERVIEW: Sudden Cardiac Arrest: A Leading Cause of Death; Cardiac Rhythm Management (CRM): A Definition; Cardiac Rhythm Disorders: A Brief Review
5. PRODUCT APPROVALS/INTRODUCTIONS: Boston Scientific Unveils CRM Connector System; Biosense Catheter Receives FDA Marketing Approval; St. Jude Medical Secures Approval for Atlas II ICD from Japan; Zoll Medical Defibrillators Receive FDA Clearance; St. Jude Medical Receives CE Mark for Integrated Irrigation Pump and Ablation Generator; AtriCure Secures FDA 510(k) Approval for Coolrail Device; Hansen Medical Gains FDA Approval for CoHesion™ Module; St. Jude Medical Obtains CE Mark and FDA Approval for HIFU Surgical Ablation Solutions; Biosense Releases NAVISTAR® RMT THERMOCOOL® Catheter; Atricure Unveils The ORLab™; Cardima Receives SFDA Approval to Market INTELLITEMP® in China; ZOLL Obtains 510K Clearance to Sell and Market Zoll R Series Code-Ready Defibrillator; ST. Jude Medical Obtains FDA and CE Mark Approval for New Epicor LP Cardiac Ablation System; Cardima Obtains Approval for Marketing Surgical Ablation System in Thailand; ATS Medical Introduces First CryoMaze Surgical Ablation Clamp; CardioNet Unveils New Reporting Package for Atrial Fibrillation Treatment; Boston Scientific Defibrillator Receives CE Mark Approval; TyRx Introduces New Anti-bacterial Envelope, AIGISRX™ ICD; St. Jude Medical Receives Approval from Japanese MHLW; Boston Scientific Secures FDA Approval for CRM Solutions; Sorin Group Develops New-Generation CRT-D Implants; BSC Secures CE Mark Approval for ALTRUA Pacemakers; Medtronic Secures FDA Approval for New Vision 3D Devices; Medtronic Obtains FDA Approval for Software Update; St. Jude Medical Obtains FDA Approval for SJM Cardiac Monitor; Boston Scientific Obtains Approval For Cognis CRT-D And Teligen ICD; FDA Approves Medtronic’s Medtronic Sprint Quattro Secure® S Lead; Medtronic Obtains CE Mark Approval for Pacemaker and Pacing Leads; St. Jude Medical Obtains Japanese Approval for Victory® Pacemakers Family; Sorin Group Obtains Approval For Isoline Defibrillation Leads In Japan; BSC Secures FDA Approval for New ALTRUA Pacemakers; St. Jude Medical Obtains Approval for Durata Defibrillation Lead; St. Jude Medical Obtains Japanese Approval for Durata Defibrillation Lead; St. Jude Medical Obtains Japanese Approval for Victory Family of Pacemakers; Sorin Group Gains FDA Approval for OVATIO™; Sorin SpA Gains FDA Approval for REPLY; Medtronic Receives Approval for Lead Integrity Alert™; Physio-Control Gains FDA Approval for LIFEPAK® 20e Defibrillator/Monitor; TyRx Introduces New Anti-Bacterial Envelope, AIGISRX™ ICD; LifeWatch Introduces Next-Generation Monitor, LifeStar ACT III Platinum; eCardio Launches eVolution, New Cardiac Monitoring System; Philips Introduces PageWriter TC70 Cardiograph; Sorin Group Announces Commercial Release and First Implant of PARADYM™ CRT; St. Jude Medical Introduces QuickOpt® Timing Cycle Optimization in CRT-D; Cardiac Science Unveils Simple Electronic Reporting System; Mennen Medical Introduces VitaLogik® 4000 Line; BIOTRONIK Releases CRT-P in US Market; Vermed Releases Defibrillation Pads Series and Universal Connector System; St. Jude Releases Reflexion Spiral X™ in US
6. RECENT INDUSTRY ACTIVITY: Novation Partners St. Jude Medical for CRM Products; Medtronic Sets Up Production Unit in Singapore; Novation Collaborates with BIOTRONIK; Boston Scientific Inks Agreement with Fukuda Denshi; Creganna Closes Tactx Medical Acquisition; Medtronic Takes Over Ablation Frontiers; Sorin Enters into Agreement with Orange Business Services; Philips Signs a Deal with Bard Electrophysiology; Boston Scientific Bags CRM Contract from Dept. of Veterans Affairs; Medtronic and Boston Scientific Inks Agreement to End IP Disputes; St Jude Medical to Invest in Penang; Cardima Enters into a Distribution Agreement with Peerless Medical; Cardiac Science Enters into an Alliance with Boy Scouts of America; Cardima Enters into a New Strategic Surgical Alliance with Biocore; Cardima Enters into a New Strategic Marketing Alliance with On-X Life Technologies; Welch Allyn and ZOLL Medical Corporation Collaborate; Cardima Selects Dot Medical to Distribute Its EP Products in the UK; Royal Philips to Guide ‘euHeart’ Project; Target Center Acquires HeartSine® Defibrillators; St Jude Medical Acquires EP MedSystems; St. Jude Takes Over Radi Medical AB; Medrad to Acquire Possis; Phoenix Acquires Stake in Possis; Biotronik Acquires VascoMed; Medtronic Takes Over CryoCath Technologies; Boston Scientific Takes Over CryoCor; St. Jude Completes Acquisition of MediGuide; Greatbatch Enters Into A Strategic Partnership With Issys; Sorin Group Inks Collaborative Agreement with Greatbatch; Philips Enters into MOU with King’s College London on Research Collaboration; Welch Allyn Collaborates with ZOLL Medical Corporation; ZOLL and HealthTrust Sign Purchasing Deal; ZOLL Inks Multi-Year Agreement with Masimo; First Responder Wins Contract from Harvard School of Public Health; Beijing Airport Group to Deploy ZOLL AED Plus Solutions; STH NHS Trust to Deploy New R Series BLS Solutions of ZOLL; Major EMS Centers in China Deploys ZOLL M Series Defibrillator; DRF to Deploy corpuls3 Heart Defibrillators; Riedel & Schulz and GS Elektromed Distributes 8 corpuls3 Medical Units; Trivitron Inks Marketing And Distribution Agreement With Boston Scientific; CardioComm Signs Licensing Agreement with GE Healthcare; Cambridge Heart Licenses Technology for Implantable Devices; Synovis Life Technologies to Divest Interventional Business; Boston Scientific Divests Cardiac Surgery And Vascular Surgery Businesses; Sorin Group Sells Its Vascular Therapy Business to CIDl
7. FOCUS ON SELECT PLAYERS: Bard Electrophysiology (US); Biosense Webster, Inc. (US); Biotronik GMBH & Co. KG (Germany); Boston Scientific Corporation (US); Medtronic, Inc. (US); Philips Healthcare (The Netherlands); St. Jude Medical, Inc. (US); Sorin Group (Italy)
8. GLOBAL MARKET PERSPECTIVE: Table 7: World Recent Past, Current & Future Analysisfor Cardiac Rhythm Management Devices by GeographicRegion - US, Europe, Asia-Pacific and Rest of WorldMarkets Independently Analyzed with Annual SalesFigures in US$ Million for Years 2009 through 2017(includes corresponding Graph/Chart); Table 8: World Historic Review for Cardiac RhythmManagement Devices by Geographic Region - US, Europe,Asia-Pacific and Rest of World Markets Independently Analyzedwith Annual Sales Figures in US$ Million for Years 2003through 2008 (includes corresponding Graph/Chart); Table 9: World 15-Year Perspective for Cardiac Rhythm Management Devices by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe, Asia-Pacificand Rest of World Markets for Years 2003, 2010 & 2017(includes corresponding Graph/Chart); Table 10: World Recent Past, Current & Future Analysisfor Implantable Cardioverter Defibrillators by Geographic Region - US, Europe, Asia-Pacific and Rest of WorldMarkets Independently Analyzed with Annual SalesFigures in US$ Million for Years 2009 through 2017(includes corresponding Graph/Chart); Table 11: World Historic Review for ImplantableCardioverter Defibrillators by Geographic Region - US,Europe, Asia-Pacific and Rest of World MarketsIndependently Analyzed with Annual Sales Figuresin US$ Million for Years 2003 through 2008(includes corresponding Graph/Chart); Table 12: World 15-Year Perspective for Implantable Cardioverter Defibrillators by Geographic Region -Percentage Breakdown of Dollar Sales for US, Europe,Asia-Pacific and Rest of World Markets) for Years 2003,2010 & 2017 (includes corresponding Graph/Chart); Table 13: World Recent Past, Current & Future Analysisfor Pacemakers by Geographic Region - US, Europe, Asia-Pacific and Rest of World Markets Independently Analyzedwith Annual Sales Figures in US$ Million for Years 2009through 2017 (includes corresponding Graph/Chart); Table 14: World Historic Review for Pacemakers byGeographic Region - US, Europe, Asia-Pacific andRest of World Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2003through 2008 (includes corresponding Graph/Chart); Table 15: World 15-Year Perspective for Pacemakers by Geographic Region - Percentage Breakdown of Dollar Salesfor US, Europe, Asia-Pacific and Rest of World Markets)for Years 2003, 2010 & 2017 (includes corresponding Graph/Chart); Table 16: World Recent Past, Current & Future Analysisfor External Defibrillators by Geographic Region - US,Europe, Asia-Pacific and Rest of World MarketsIndependently Analyzed with Annual Sales Figuresin US$ Million for Years 2009 through 2017(includes corresponding Graph/Chart); Table 17: World Historic Review for External Defibrillatorsby Geographic Region - US, Europe, Asia-Pacific andRest of World Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2003through 2008 (includes corresponding Graph/Chart); Table 18: World 15-Year Perspective for ExternalDefibrillators by Geographic Region - PercentageBreakdown of Dollar Sales for US, Europe, Asia-Pacificand Rest of World Markets) for Years 2003, 2010 &2017 (includes corresponding Graph/Chart); Table 19: World Recent Past, Current & Future Analysisfor EP Catheterization, Mapping, & Ablation (CMA) by Geographic Region - US, Europe, Asia-Pacific andRest of World Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2009through 2017 (includes corresponding Graph/Chart); Table 20: World Historic Review for EP Catheterization, Mapping, & Ablation (CMA)by Geographic Region - US,Europe, Asia-Pacific and Rest of World MarketsIndependently Analyzed with Annual Sales Figuresin US$ Million for Years 2003 through 2008(includes corresponding Graph/Chart); Table 21: World 15-Year Perspective for EP Catheterization, Mapping, & Ablation (CMA) by Geographic Region -Percentage Breakdown of Dollar Sales for US, Europe,Asia-Pacific and Rest of World Markets) for Years 2003,2010 & 2017 (includes corresponding Graph/Chart)
9. THE UNITED STATES: A. Market Analysis; B. Market Analytics
10. EUROPE: A. Market Analysis; B. Market Analytics
11. ASIA PACIFIC: A. Market Analysis; B. Market Analytics
12. REST OF WORLD: A. Market Analysis; B. Market Analytics
COMPETITIVE LANDSCAPE: Total Companies Profiled: 48 (including Divisions/Subsidiaries - 125)Region/Country Players; The United States; Canada 7; Japan 8; Europe; Asia-Pacific (Excluding Japan) 10; Latin America 2Africa 1

More Global Cardiovascular Devices Reports

The Global Market for Medical Devices, 3rd. Edition by Kalorama Information
Medical device makers faced a productive but challenging year in 2011. They innovated existing lines, launched new devices and invested in R&D. But they ...

Global Medical Devices Survey 2012–2013: Market Trends, Marketing Spend and Sales Strategies in the Global Medical Devices Industry by iCD Research
Synopsis “Global Medical Devices Survey 2012–2013: Market Trends, Marketing Spend and Sales Strategies in the Global Medical Devices Industry” is a new report by ICD ...

Global Medical Devices Survey 2012–2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Medical Devices Industry by iCD Research
Synopsis “Global Medical Devices Survey 2012–2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Medical Devices Industry” is a new report by ICD ...

Peripheral Vascular & Interventional Cardiology Devices Market (2011 – 2016) (Balloons, Evar Stent Grafts, Ivc Filter, Ivus & Angiography Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices & Accessory Devices) Global Trends & Comp by MarketsandMarkets
The global vascular interventional devices market consist of devices used in both coronary and peripheral endovascular procedures which includes balloons, EVAR stent grafts, IVC filters, ...

Global Heart Valve Market Report: 2011 Edition by Koncept Analytics
The global heart valve market has recorded strong growth in the past years. During 2010, transcatheter aortic valve implant (TAVI) registered highest growth amongst all ...

See all reports like this >>

Cardiac Rhythm Management (CRM) Devices

Share this report

Other tasks

Research Assistance

Related Markets

Cardiovascular Devices Reports

Free Alert Me service